Bruker Q2 Organic Revs Rise 8 Percent, Though Receipts Slide for Second Consecutive Sequential Period | GenomeWeb

Bruker's revenues have slid for two consecutive periods, not three, as was originally reported.


NEW YORK, Aug. 3 (GenomeWeb News) - Bruker BioSciences today said that second-quarter revenue increased 11.3 percent to $71.4 million. The growth included a 3.3 percent favorable currency effect.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.